Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib can cause a delayed skin reaction on the nose.

Paraproteinemic keratopathy can show eye symptoms before other signs of disease, needing careful treatment and long-term follow-up.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Tinea capitis should be considered in adults with scalp issues for proper treatment.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Both estrogens and androgens are important for health in both males and females.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Hydroxychloroquine may help delay skin damage in lupus patients.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.